The capacity to account for or predict non-adherence with understood risk-aspects is still poor despite the discovery of an immense variety of substantial adherence predictors. During the first three years of treating type 2 diabetes, researchers have observed medication non-adherence driven by three special patterns (García-Pérez, Álvarez, Dilla, Gil-Guillén, and Orozco-Beltrán, 2013). The patterns are prime non-adherence, non-persistence, and noncompliance or poor administration. Prime non-adherence entails patients who get a prescription but at no time get the actual medicine. For type 2 antidiabetic medications, the occurrence of prime non-adherence ranges from 4% to 31% although troublesome symptoms would be likely for patients who do not get sugar-lowering medicine (Harrison and Lingvay, 2013).Medication non-adherence for type 2 diabetes is very high in both intervention and control sets, making it hard for researchers to evaluate the performance of certain nursing approaches (Joanna Briggs Institute, 2011). Researchers are conducting studies on continuation visits aimed at improving medication adherence for type 2 diabetes patients, frequently with little coordination to the real prescribing doctor. Physicians and pharmacists cannot inhibit medication non-adherence for type 2 diabetes if the healthcare system removes medicine costs for patients fully (Blackburn et al. Adherence to medication has many potential contributing factors. As a result, removing one barrier, even a factor as vital as cost, is not a solution to medical non-adherence amongst type 2 diabetes patients (Salas, Hughes, Zuluaga, Vardeva, and Lebmeier, 2009). In addition, small developments to a myriad of medicines might have significant decreases in morbidity related to type 2 diabetes.Two medication regimens that can manage type 2 diabetes are basal or background insulin dosage and basal-bolus regimens. To cater to overnight insulin needs, a pharmacist prescribes the basal or background insulin dosage as an intermediate regimen for type 2 diabetes (Sharma et al. Physicians largely prescribe this regimen together with short-term insulin injections to provide better adaptability. This regimen is widely used when the pharmacist decides to use intensified insulin medication to ensure optimum glycemic control. As a regimen, patients
Blackburn, D. F., Swidrovich, J. and Lemstra, M. (2013). Nonadherence in type 2 diabetes: practical considerations for interpreting the literature. Patient Prefer Adherence, 2013(7): pp. 183—189.
García-Pérez, L., Álvarez, M., Dilla, T., Gil-Guillén, V., and Orozco-Beltrán, D. (2013). Adherence to Therapies in Patients with Type 2 Diabetes. Diabetes Therapy, 4(2): 175– 194.
Harrison, L. B. and Lingvay, I. (2013). Appointment and medication non-adherence is associated with increased mortality in insulin-treated type 2 diabetes. Evidence Based Medicine, 18: pp. 112-113.
Hunt, C. W. (2013). Self-care management strategies among individuals living with type 2 diabetes mellitus: nursing interventions. Nursing: Research and Reviews, 3: pp. 99–105.
Joanna Briggs Institute. (2011). Educational interventions to promote oral hypoglycaemic adherence in adults with Type 2 diabetes. Best Practice 15(11): pp. 1-3.
Salas, M., Hughes, D., Zuluaga, A., Vardeva, K., and Lebmeier, M. (2009). Costs of Medication Nonadherence in Patients with Diabetes Mellitus: A Systematic Review and Critical Analysis of the Literature. International Society for Pharmacoeconomics and Outcomes Research (ISPOR), 12(6): pp.915-922.
Schoenthaler, A., and Cuffee, Y. L. (2013). A Systematic Review of Interventions to Improve Adherence to Diabetes Medications within the Patient–Practitioner Interaction. JCOM, 20(11): pp. 494-506.
Sharma, T., Kalra, J., Dhasmana, D. C. and Basera, H. (2014). Poor adherence to treatment: A major challenge in diabetes. JIACM, 15(1): pp. 26-9.
Please type your essay title, choose your document type, enter your email and we send you essay samples